Based on preliminary searches, analyst expectations for AbbVie's Q3 2025 revenue were approximately $16 billion and EPS around $3. Revenue came in lower at $15.776 billion, and EPS significantly missed expectations at $0.1. Therefore, AbbVie missed on both revenue and EPS, leading to a 'Somewhat negative' sentiment.
Analysis Details
AI-POWERED INSIGHTSAffected Securities
SourceAbbVie Inc.
PublishedNovember 4, 2025 at 7:05 PM Historical Context
AI Confidence70% Moderate
ImplicationPotential headwinds for related securities
Disclaimer: This analysis is for informational purposes only and should not be considered financial advice. Always consult with a qualified financial advisor before making investment decisions.